150 related articles for article (PubMed ID: 11085234)
1. Assessment of protective immune responses against hydatid disease in sheep by immunization with synthetic peptide antigens.
Woollard DJ; Heath DD; Lightowlers MW
Parasitology; 2000 Aug; 121 ( Pt 2)():145-53. PubMed ID: 11085234
[TBL] [Abstract][Full Text] [Related]
2. Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes.
Woollard DJ; Gauci CG; Heath DD; Lightowlers MW
Vaccine; 2000 Oct; 19(4-5):498-507. PubMed ID: 11027814
[TBL] [Abstract][Full Text] [Related]
3. Synthetic peptides induce antibody against a host-protective antigen of Echinococcus granulosus.
Woollard DJ; Gauci CG; Lightowlers MW
Vaccine; 1999 Dec; 18(9-10):785-94. PubMed ID: 10580190
[TBL] [Abstract][Full Text] [Related]
4. Epitope specificities and antibody responses to the EG95 hydatid vaccine.
Woollard DJ; Gauci CG; Heath DD; Lightowlers MW
Parasite Immunol; 1998 Nov; 20(11):535-40. PubMed ID: 9988310
[TBL] [Abstract][Full Text] [Related]
5. Antigenic differences between the EG95-related proteins from Echinococcus granulosus G1 and G6 genotypes: implications for vaccination.
Alvarez Rojas CA; Gauci CG; Lightowlers MW
Parasite Immunol; 2013 Feb; 35(2):99-102. PubMed ID: 23009356
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of three enzyme-linked immunosorbent assays (ELISAs) for the detection of serum antibodies in sheep infected with Echinococcus granulosus.
Kittelberger R; Reichel MP; Jenner J; Heath DD; Lightowlers MW; Moro P; Ibrahem MM; Craig PS; O'Keefe JS
Vet Parasitol; 2002 Dec; 110(1-2):57-76. PubMed ID: 12446090
[TBL] [Abstract][Full Text] [Related]
7. Serological monitoring of protection of sheep against Echinococcus granulosus induced by the EG95 vaccine.
Heath DD; Koolaard J
Parasite Immunol; 2012 Jan; 34(1):40-4. PubMed ID: 22043983
[TBL] [Abstract][Full Text] [Related]
8. Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep.
Lightowlers MW; Jensen O; Fernandez E; Iriarte JA; Woollard DJ; Gauci CG; Jenkins DJ; Heath DD
Int J Parasitol; 1999 Apr; 29(4):531-4. PubMed ID: 10428628
[TBL] [Abstract][Full Text] [Related]
9. Delivery of Echinococcus granulosus antigen EG95 to mice and sheep using recombinant vaccinia virus.
Dutton S; Fleming SB; Ueda N; Heath DD; Hibma MH; Mercer AA
Parasite Immunol; 2012 Jun; 34(6):312-7. PubMed ID: 22404504
[TBL] [Abstract][Full Text] [Related]
10. Immunological responses and potency of the EG95NC
Jazouli M; Lightowlers MW; Bamouh Z; Gauci CG; Tadlaoui K; Ennaji MM; Elharrak M
Parasitol Int; 2020 Oct; 78():102149. PubMed ID: 32464256
[TBL] [Abstract][Full Text] [Related]
11. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy.
Scheerlinck JP; Casey G; McWaters P; Kelly J; Woollard D; Lightowlers MW; Tennent JM; Chaplin PJ
Vaccine; 2001 Jul; 19(28-29):4053-60. PubMed ID: 11427282
[TBL] [Abstract][Full Text] [Related]
12. Serology and longevity of immunity against Echinococcus granulosus in sheep and llama induced by an oil-based EG95 vaccine.
Poggio TV; Jensen O; Mossello M; Iriarte J; Avila HG; Gertiser ML; Serafino JJ; Romero S; Echenique MA; Dominguez DE; Barrios JR; Heath D
Parasite Immunol; 2016 Aug; 38(8):496-502. PubMed ID: 27104482
[TBL] [Abstract][Full Text] [Related]
13. Antigenic polypeptides of Echinococcus granulosus oncospheres and definition of protective molecules.
Heath DD; Lawrence SB
Parasite Immunol; 1996 Jul; 18(7):347-57. PubMed ID: 9229388
[TBL] [Abstract][Full Text] [Related]
14. Immunity and vaccine control of Echinococcus granulosus infection in animal intermediate hosts.
Lightowlers MW; Heath DD
Parassitologia; 2004 Jun; 46(1-2):27-31. PubMed ID: 15305682
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with recombinant oncosphere antigens reduces the susceptibility of sheep to infection with Taenia multiceps.
Gauci C; Vural G; Oncel T; Varcasia A; Damian V; Kyngdon CT; Craig PS; Anderson GA; Lightowlers MW
Int J Parasitol; 2008 Jul; 38(8-9):1041-50. PubMed ID: 18160069
[TBL] [Abstract][Full Text] [Related]
16. Maternal antibody parameters of cattle and calves receiving EG95 vaccine to protect against Echinococcus granulosus.
Heath DD; Robinson C; Lightowlers MW
Vaccine; 2012 Nov; 30(50):7321-6. PubMed ID: 22981849
[TBL] [Abstract][Full Text] [Related]
17. Development of orf virus as a bifunctional recombinant vaccine: surface display of Echinococcus granulosus antigen EG95 by fusion to membrane structural proteins.
Tan JL; Ueda N; Heath D; Mercer AA; Fleming SB
Vaccine; 2012 Jan; 30(2):398-406. PubMed ID: 22085551
[TBL] [Abstract][Full Text] [Related]
18. Isolation of antibodies specific to a single conformation-dependant antigenic determinant on the EG95 hydatid vaccine.
Read AJ; Casey JL; Coley AM; Foley M; Gauci CG; Jackson DC; Lightowlers MW
Vaccine; 2009 Feb; 27(7):1024-31. PubMed ID: 19095030
[TBL] [Abstract][Full Text] [Related]
19. Short report: Echinococcus granulosus from Xinjiang, PR China: cDNAS encoding the EG95 vaccine antigen are expressed in different life cycle stages and are conserved in the oncosphere.
Zhang W; Li J; You H; Zhang Z; Turson G; Loukas A; McManus DP
Am J Trop Med Hyg; 2003 Jan; 68(1):40-3. PubMed ID: 12556145
[TBL] [Abstract][Full Text] [Related]
20. Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: Humoral response to the vaccine.
Larrieu E; Poggio TV; Mujica G; Gauci CG; Labanchi JL; Herrero E; Araya D; Grizmado C; Calabro A; Talmon G; Crowley P; Santillán G; Vizcaychipi K; Seleiman M; Sepulveda L; Arezo M; Cachau MG; Lamberti R; Molina L; Gino L; Donadeu M; Lightowlers MW
Parasitol Int; 2017 Jun; 66(3):258-261. PubMed ID: 28167154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
